The Biophotonics and Bioengineering Laboratory (BBL) is a research lab started in 2008 lead by Principal Investigator Dr. Victor Yang. The lab focuses on using optically based methodologies and modalities for translational research, with the overarching goal of merging biomedical engineering and device development with clinical practice. Presently, research is conducted at Ryerson University, the University of Toronto, and Sunnybrook Health Sciences Centre and Research Institute.
Presently, the research group specializes in research in imaging with focus on Optical Coherence Tomography (OCT) with focus on speckle-variance (SV-OCT), Doppler (DOCT), and Intravascular OCT, Optical Topographic Imaging (OTI), Photodynamic Therapy (PDT), and High-frequency Ultrasound Imaging (HiFUS). Further research is currently being conducted in hard and soft-tissue ablation, biomedical phantom development, aneurysm simulation, hemodynamics and treatment, photodynamic therapy (PDT), radiotherapy and radiation dosimetry planning, medical robotics, and augmented reality for surgery. For a more complete list, please see the research foci page here.
The BBL also works closely with a number of industrial partners. These partners include 7D Surgical, Michelson Diagnostics Ltd., VisualSonics, Kuka Robotics, and BC Cancer Agency. For a description of our industry partners, as well as other associated groups, and websites, please see the Partners and Links page here.
The BBL is comprised of 17 full-time members, including 6 Engineering graduate students, 4 graduate students from the Institute of Medical Sciences, and 1 graduate student in medical biophysics. For a complete list of lab personnel, please see the Lab Members page here.